Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026 (forecast)
2027
2028
2029
2030
2031
Trend
ROE
-75.8%
-105.95%
-274.73%
159.56%
68.09%
43.84%
32.19%
ROA
-44.8%
-66.78%
-113.57%
-183.38%
-191.66%
-188.26%
-185.75%
Gross Margin
3.75%
1.54%
1.54%
1.54%
1.54%
1.54%
1.54%
Sector average
-
17.71%
17.71%
17.71%
17.71%
17.71%
62.35%
Total Assets
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for ExpreS2ion Biotech Holding AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
SEK 65,108.00K
SEK 57,793.00K
SEK 27,359.48K
SEK 29,244.20K
SEK 33,758.45K
SEK 37,142.26K
SEK 39,506.93K
Sector average
-
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
SEK 1,806,991.80K
Net Income
-SEK 38,085.00K
-SEK 41,036.49K
-SEK 48,354.55K
-SEK 51,899.99K
-SEK 60,374.40K
-SEK 66,738.01K
-SEK 71,189.68K
Sector average
-
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
-SEK 13,704.11K
Valuation
-
SEK 157,144.15K
SEK 185,167.76K
SEK 198,744.59K
SEK 231,196.29K
SEK 255,564.93K
SEK 272,612.06K
Sector average
-
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
SEK 3,179,755.44K
Stock Price
-
SEK 15.90
SEK 18.74
SEK 20.11
SEK 23.39
SEK 25.86
SEK 27.58
Sector average
-
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
SEK 36.70
ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) Financial Forecast | Equlion
